A PROSPECTIVE, RANDOMIZED, PHASE II STUDY OFGISL COMPARING TWO MITOXANTRONE-BASED SALVAGEPROGRAM (MIPE VS MJMA) IN AGGRESSIVE NON-HODGKIN’SLYMPHOMA (ANHL) FAILING AN ANTHRACYCLINECONTAININGFRONT-LINE TREATMENT